IDDF2018-ABS-0211 Altered coagulation in inflammatory bowel disease: predictors of the disease status

Juntao Lu,Lijie Lai,Yuqi Qiao,Dongjuan Song,Jun Shen,Zhihua Ran
DOI: https://doi.org/10.1136/gutjnl-2018-IDDFabstracts.156
IF: 24.5
2018-01-01
Gut
Abstract:Background To evaluate the coagulation status in patients with inflammatory bowel disease (IBD) and explore the possibility of using coagulation parameters to predict the disease status and assist the diagnosis. Methods We enrolled 987 hospitalised IBD patients and 1027 healthy controls during March 2011 to June 2016. The coagulation parameters between IBD patients and healthy controls were compared. Correlations between coagulation and disease status were evaluated. Computer-based machine learning including artificial neural network (ANN) and support vector machine (SVM), together with receiving operator curve (ROC) was used to estimate the value of coagulation parameters in the diagnosis of IBD. Results Compared with healthy controls, IBD patients showed higher platelet count and plateletcrit, lower mean platelet volume, platelet distribution width and platelet-large cell ratio, prolonged prothrombin time and activated partial thromboplastin time, and increased fibrinogen and INR (p Conclusions Hyper-coagulation is present in IBD patients. Disease status and coagulation are closely correlated. In CD patients, coagulation parameters are able to indicate the level of inflammatory biomarkers, the location of the lesion, disease behaviour as well as the presence of perianal disease while in UC patients, coagulation parameters are indicative of the the level of inflammatory biomarkers, endoscopic activity and disease extent.
What problem does this paper attempt to address?